458 related articles for article (PubMed ID: 32258135)
21. Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
Naidoo M; Piercey O; Tie J
Curr Oncol Rep; 2021 Nov; 23(12):140. PubMed ID: 34735665
[TBL] [Abstract][Full Text] [Related]
22. Liquid Biopsy: Current Status and Future Perspectives.
Mader S; Pantel K
Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
24. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
[TBL] [Abstract][Full Text] [Related]
25. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
Haupts A; Roth W; Hartmann N
Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
[TBL] [Abstract][Full Text] [Related]
26. Liquid biopsy enters the clinic - implementation issues and future challenges.
Ignatiadis M; Sledge GW; Jeffrey SS
Nat Rev Clin Oncol; 2021 May; 18(5):297-312. PubMed ID: 33473219
[TBL] [Abstract][Full Text] [Related]
27. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
Egyud M; Sridhar P; Devaiah A; Yamada E; Saunders S; Ståhlberg A; Filges S; Krzyzanowski PM; Kalatskaya I; Jiao W; Stein LD; Jalisi S; Godfrey TE
Head Neck; 2019 May; 41(5):1351-1358. PubMed ID: 30554450
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data.
Huang K; Qu H; Zhang X; Huang T; Sun X; He W; Li M; Lin L; Xu M; Chen S; Xia L
Cancer Biomark; 2019; 26(3):313-322. PubMed ID: 31561327
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
30. Role of circulating tumor DNA in the management of early-stage lung cancer.
Zhao H; Chen KZ; Hui BG; Zhang K; Yang F; Wang J
Thorac Cancer; 2018 May; 9(5):509-515. PubMed ID: 29528556
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
32. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
[TBL] [Abstract][Full Text] [Related]
33. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
García-Foncillas J; Alba E; Aranda E; Díaz-Rubio E; López-López R; Tabernero J; Vivancos A
Ann Oncol; 2017 Dec; 28(12):2943-2949. PubMed ID: 28945877
[TBL] [Abstract][Full Text] [Related]
34. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
35. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
[TBL] [Abstract][Full Text] [Related]
36. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
37. Clinical implementation and current advancement of blood liquid biopsy in cancer.
Watanabe K; Nakamura Y; Low SK
J Hum Genet; 2021 Sep; 66(9):909-926. PubMed ID: 34088974
[TBL] [Abstract][Full Text] [Related]
38. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th edition.
Ebi H; Bando H; Taniguchi H; Sunakawa Y; Okugawa Y; Hatanaka Y; Hosoda W; Kumamoto K; Nakatani K; Yamazaki K
Cancer Sci; 2020 Oct; 111(10):3962-3969. PubMed ID: 32667108
[TBL] [Abstract][Full Text] [Related]
39. Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial.
Bidard FC; Kiavue N; Ychou M; Cabel L; Stern MH; Madic J; Saliou A; Rampanou A; Decraene C; Bouché O; Rivoire M; Ghiringhelli F; Francois E; Guimbaud R; Mineur L; Khemissa-Akouz F; Mazard T; Moussata D; Proudhon C; Pierga JY; Stanbury T; Thézenas S; Mariani P
Cells; 2019 May; 8(6):. PubMed ID: 31142037
[TBL] [Abstract][Full Text] [Related]
40. [Possibilities of liquid biopsy in gastric cancer].
Zakharenko AA; Zaitsev DA; Belyaev MA; Trushin AA; Ten OA; Natkha AS
Vopr Onkol; 2016; 62(4):379-85. PubMed ID: 30474943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
